Berkeley Lights, Inc. announced that Eric D. Hobbs, Ph.D. will transition from his role as member of the board of directors to president of the Antibody Therapeutics business line. Dr. Hobbs will continue to serve in his role as member of the board of directors until the appointment of his successor.
Bruker Cellular Analysis, Inc.
Equities
BLI
US0843101017
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+16.91% | 4.44TCr | |
+42.04% | 4TCr | |
-11.19% | 3.77TCr | |
+29.36% | 3.15TCr | |
-9.23% | 2.73TCr | |
+12.39% | 2.63TCr | |
+42.08% | 1.38TCr | |
+30.13% | 1.25TCr | |
-8.13% | 1.13TCr |